Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Lycorine (hydrochloride)

Lycorine hydrochloride is the main active ingredient of the herbal medicine derived from Lycoris radiata (L’Her.) Herb. and is also a melanoma vasculogenic inhibitor and has anti-tumor activity[1]. Lycorine hydrochloride effectively inhibits mitotic proliferation of Hey1B cells (IC50 of 1.2 μM) [2].

Product Specifications

CAS Number

[2188-68-3]

UNSPSC

12352005

Hazard Statement

H301

Target

Autophagy; Bacterial; Virus Protease

Type

Natural Products

Related Pathways

Anti-infection; Autophagy

Applications

Cancer-programmed cell death

Field of Research

Cancer; Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/Lycorine-hydrochloride.html

Purity

99.89

Solubility

DMSO : 125 mg/mL (ultrasonic) |H2O : 16.67 mg/mL (ultrasonic)

Smiles

O[C@@H]1[C@@H](O)C=C(CC2)[C@@]3([H])N2CC4=C([C@@]31[H])C=C(OCO5)C5=C4.Cl

Molecular Formula

C16H18ClNO4

Molecular Weight

323.77

Precautions

H301

References & Citations

[1]Liu, R. et al. Lycorine hydrochloride inhibits metastatic melanoma cell-dominant vasculogenic mimicry. Pigment cell & melanoma research 25, 630-638, doi:10.1111/j.1755-148X.2012.01036.x (2012) .|[2]Cao, Z. et al.Lycorine hydrochloride selectively inhibits human ovarian cancer cell proliferation and tumor neovascularization with very low toxicity. Toxicology letters 218, 174-185, doi:10.1016/j.toxlet.2013.01.018 (2013) .

Shipping Conditions

Room Temperature

Storage Conditions

4°C (Powder, sealed storage, away from moisture)

Scientific Category

Natural Products

Clinical Information

No Development Reported

Citation 01

BioRxiv. 2024 Feb 6:2024.02.06.579103.|Cancers (Basel) . 2025 Feb 20;17 (5) :718.|Patent. US20230014181.|Preprints. 2024 Nov.|Ann Hematol. 2023 May;102 (5) :1073-1086.|Antiviral Res. 2024 Jul 2:228:105955.|Eur J Pharmacol. 2023 Dec 15:961:176162.|Int J Mol Med. 2022 Dec;50 (6) :145.|Int J Mol Sci. 2025 Jun 3;26 (11) :5358.|J Exp Clin Cancer Res. 2022 Mar 30;41 (1) :116.|Microorganisms. 2022 Oct 21;10 (10) :2089.|Mol Med Rep. 2024 Mar;29 (3) :48.|Oncol Lett. 2021 Nov;22 (5) :781.|Pharmacol Res. 2022 Jan:175:105985.|Research Square Preprint. 2022 Feb.|Research Square Preprint. 2022 Jan.

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

TBX15 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)
46300066 1.0 µg DNA

TBX15 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)

Ask
View Details
Neratinib Impurity 20
RM-N051820-01 10 mg

Neratinib Impurity 20

Ask
View Details
Neratinib Impurity 20
RM-N051820-02 25 mg

Neratinib Impurity 20

Ask
View Details
Neratinib Impurity 20
RM-N051820-03 50 mg

Neratinib Impurity 20

Ask
View Details
Neratinib Impurity 20
RM-N051820-04 100 mg

Neratinib Impurity 20

Ask
View Details
ITGA7 (Integrin, alpha 7, FLJ25220) (APC)
247753-APC 100 µL

ITGA7 (Integrin, alpha 7, FLJ25220) (APC)

Ask
View Details